摘要
目的观察乌司他丁联合常规治疗方案治疗急性重症胰腺炎的效果及预后。方法回顾性对比分析急性重症胰腺炎常规治疗联合乌司他丁及单纯常规治疗各30例的治疗结果及预后。结果联合乌司他丁治疗组的腹部症状、体征、实验室各指标及肺功能恢复,和对比组比较有显著差异(P<0.05);在白细胞总数恢复时间上无明显差异,但有缩短趋势;ARDS发生率下降,总体病死率下降。结论联合乌司他丁治疗急性重症胰腺炎能更快地控制病情,抑制体内炎症反应,减少ARDS发生率,明显缩短病程。
Objective To observe the effects and prognosis of Ulinastatin combined with routine therapy on acute pancreatitis. Methods Retrospective analysis were focused on the effects and prognosis of 30 acute serious pancreatitis patients with routine treatment and routine treatment combined with Ulinastatin respectively. Results The differences on abdomen symptoms, lab index, physical sign, restitution of pulmonary function between treatment group and control group are significant. （P〈0.05） There are no significant differences on restoration time of white blood cells, but there is a shortening tendency. The incidence rate of ARDS and total death rate descend. Conclusion The treatment combined with Ulinastatin can rapidly control the condition of acute pancreatitis, inhibit the inflammation reaction, descend the incidence rate of ARDS and can obviously shorten the course of disease.
出处
《山西大同大学学报（自然科学版）》
2011年第6期46-48,共3页
Journal of Shanxi Datong University(Natural Science Edition)
关键词
重症胰腺炎
乌司他丁
联合治疗
serious pancreatitis
Ulinastatin
routine therapy
